We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$604M
AUM Growth
+$59.9M
Cap. Flow
+$15.9M
Cap. Flow %
2.64%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
3
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$12.8M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$2.83M
3
LCTX icon
Lineage Cell Therapeutics
LCTX
+$453K

Top Sells

Rank Stock Value
1
AST.WS
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
+$164K

Sector Composition

Rank Sector Weight
1 Healthcare 45.79%
2 Consumer Staples 43.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$265M 43.9%
9,594,816
– –
STAA icon
2
STAAR Surgical
STAA
$1.21B
$135M 22.38%
10,855,179
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$269M
$77.5M 12.83%
31,180,187
+182,880
+0.6% +$453K
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$62.2M 10.31%
420,000
– –
IMDX
5
Insight Molecular Diagnostics
IMDX
$150M
$27.2M 4.5%
179,834
+27,000
+18% +$2.83M
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$24.1M 3.99%
644,822
+322,411
+100% +$12.8M
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$12.6M 2.08%
3,699,848
– –
AST.WS
8
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
– –
-328,205
Closed -$164K

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Broadwood Capital held 8 positions worth $604M, up 11% from $544M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q3 2017 filing shows 3 increased and 1 closed positions. The largest sale was Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017), an estimated $164K.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2017, an estimated $12.8M increase.
  • Broadwood Capital fully exited Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q3 2017, selling an estimated $164K.
  • Broadwood Capital's ten largest holdings make up 100% of its $604M portfolio in Q3 2017.
  • Broadwood Capital opened 0 new positions and closed 1 in Q3 2017.
  • Broadwood Capital's portfolio value rose 11% quarter-over-quarter to $604M.

Based on Broadwood Capital's 13F filing for Q3 2017, filed 14 Nov 2017.